Chimera Investment Corp. (CIM.PRA) Quote

JAGX chart looks like a Nike swoosh symbol about to form a bowl Tcup whatever you wanna call it all points to positive. We can’t all be this stupid as investors says 141 milly shares traded that’s neat… battle again on Monday!!!!! Peace out!

maybe next week 👀

WDRP rebound time next week then onto new blue skies

New deals appear to be a bit more difficult to cobble together. I have to say, those who point out that I don’t understand this stock very well, are probably right. It is beginning to resemble an oil and gas royalty trust, in that it slowly depletes its assets - in Halozyme’s case the licensing deal

Why would anyone talk to an OTC CEO?

CONMEN need to be in personal contact to work their magic.

Phone calls are the modern-day medicine-man's preferred method shill their BS.

Educated "professionals" are the preferred marks, especially if they're in the s

NVAX a takeover target...
https://www.pharmavoice.com/news/novavax-activist-investor-pfizer-shah/715045/

I see where you responded to upticks comment to me! I have him blocked and few others! But I want to thank you for all of your support on this board and research you do!! You’re doing a fantastic job keep it up Thank you so much!! Gltu

NVAX a takeover target...
https://www.pharmavoice.com/news/novavax-activist-investor-pfizer-shah/715045/

news from earlier
$MOBILE
https://coinmarketcap.com/community/articles/6634e215924c42734bec1f2d/

OK, I’ll bite good or bad?

Of course you are referring to the power reduction within the data centers that is currently attributable to the transceivers that convert the electronic signals into light pulses that depart the data centers through fiber optic cables.

That’s not what happened today

I'm getting more bullish NSAV! I'm calling for .06 min, and a close over .06 leads to .15
This weeks chart looks so much like 2021
https://investorshub.advfn.com/uimage/uploads/2024/5/3/hxa[bNSAV_WEEKLY_5-3-24.PNG


2021 chart
https://investorshub.advfn.com/

I concur that Paxlovid 1Q24 sales and 2024 guidance are not surprising; however, I think some investors were confused by PFE's 4Q23 writeoff and didn't realize that the 2023 figure was an accounting artifact rather than a reflection of product demand.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174355296

Liked "fairy tales" speaking of...hows burnerletta doing?

I love my Tahoe… hence the name… lol

Pump Campaign needed! $CBIA

Not sure but I wasn’t surprised by paxlovid sales and think they are lowballing guidance still. They are still the only game in town in western countries although most people think ensitrelvir will be on the market here by early 2025 (although the odds went down a bit IMO when they missed their own

I followed you into UNCY when I sold out ARDX @ $7.45. ARDX owes me nothing as I entered at $1.13 long ago. Hoping to have the same return from the favorable entry in UNCY - I will continue to add on any drops that might present themselves.

You and Cosa are very in tune with the i

I would take what Saving Grace says with a grain of salt. Doesnt actually know alot about ERBB